Edition:
India

People: Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

3.27USD
19 Jul 2019
Change (% chg)

$-0.07 (-2.10%)
Prev Close
$3.34
Open
$3.33
Day's High
$3.39
Day's Low
$3.21
Volume
1,516,495
Avg. Vol
1,252,865
52-wk High
$18.50
52-wk Low
$3.21

Coughlin, Terrance 

Mr. Terrance John Coughlin is Chief Operating Officer, Executive Vice President of the Company. In this role, Mr. Coughlin has responsibility for Manufacturing and Technical Operations, as well as Endo Ventures and R&D across the enterprise. Most recently, Mr. Coughlin served as Vice President, Operations of Par Pharmaceutical Companies, Inc., a subsidiary of Endo. Prior to Endo’s acquisition of Par in September 2015, Mr. Coughlin was the Chief Operating Officer of Par Pharmaceutical Companies, Inc. Prior to joining Par, Mr. Coughlin held a number of leadership roles with Glenmark Generics, Inc. USA/Glenmark Generics Limited latterly as the President and Chief Executive Officer of Glenmark Generics, Inc. USA/Glenmark Generics Limited. Prior to this, Mr. Coughlin had the overall responsibility for Glenmark’s North American, Western European and Eastern European generics businesses, as well as its global active pharmaceutical ingredient business and generics operations in India. Prior to joining Glenmark, Mr. Coughlin served as Senior Vice President at Dr. Reddy’s Laboratories, Inc. Mr. Coughlin began his career in 1988 with Wyckoff Chemical Company, Inc. Mr. Coughlin earned a B.S. in chemistry from Central Michigan University.

Basic Compensation

Total Annual Compensation, USD 871,280
Restricted Stock Award, USD 951,113
Long-Term Incentive Plans, USD --
All Other, USD 266,598
Fiscal Year Total, USD 2,088,990

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --